SCHEMBL6174834

SCHEMBL6174834

CC(c1ccnc(C(=O)Nc2ccccc2)c1)C1NC(=O)N(c2ccc(S(=O)(=O)C(F)(F)F)cc2)C1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM1 Q13255 1/20 0.39
IGF1R P08069 2/20 0.39
CBLB Q13191 3/20 0.37
HTR2A P28223 1/20 0.37
TSPO P30536 1/20 0.37
GPR183 P32249 1/20 0.37
APLNR P35414 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
TRPV1 Q8NER1 3/20 0.36
GRM4 Q14833 5/20 0.36
PTGS1 P23219 1/20 0.36
EPHX2 P34913 1/20 0.36
PTGS2 P35354 1/20 0.36
MMP2 P08253 1/20 0.36
MMP9 P14780 1/20 0.36
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
LMNA P02545 1/20 0.35
TP53 P04637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6175142 0.86 IGF1R (0.38) IGF1REPHX2SMN1; SMN2LMNAMAPK1
SCHEMBL6175179 0.86 ABL1 (0.44) GRM1TRPV1EPHX2NPC1RAB9A
SCHEMBL6172969 0.84 DHODH (0.38) IGF1RSMN1; SMN2
SCHEMBL6174034 0.83 CBLB (0.36) IGF1RCBLBHTR2ATSPOGPR183
SCHEMBL6174217 0.83 IGF1R (0.38) IGF1RCBLBHTR2ATSPOGPR183
SCHEMBL6173893 0.82 LMNA (0.39) IGF1RCBLBHTR2ATSPOGPR183
SCHEMBL6172184 0.82 NPC1 (0.39) IGF1RCBLBNPC1RAB9ASMN1; SMN2
SCHEMBL6176514 0.81 NAMPT (0.41) IGF1RMAPK1
SCHEMBL6175133 0.81 GRM5 (0.43) CBLBNPC1RAB9ASMN1; SMN2TP53
SCHEMBL6177896 0.80 LMNA (0.48) IGF1RLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed